A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression

被引:449
作者
Rovin, BH
Lu, L
Saxena, R
机构
[1] Ohio State Univ, Div Nephrol, Dept Med, Sch Med & Publ Hlth, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Pathol, Sch Med & Publ Hlth, Columbus, OH 43210 USA
关键词
D O I
10.1006/bbrc.1999.0796
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
novel polymorphisms in the distal regulatory region of the MCP-1 gene were identified by directly sequencing PCR amplified genomic DNA. These polymorphisms are located at positions -2518 (G or A) and -2076 (A or T) relative to the major transcriptional start site of the gene. To examine the effect of these polymorphisms on MCP-1 transcription, polymorphic variants of the MCP-1 distal regulatory region were placed upstream of a luciferase reporter gene and transfected into A172 cells. IL-1 beta-induced luciferase activity was significantly greater from cells transfected with constructs containing G; at position -2518. The polymorphism at -2076 did not affect MCP-1 transcription. IL-1 beta-treated peripheral blood mononuclear cells from individuals heterozygous or homozygous for G at -2518 produced more MCP-1 than cells from individuals homozygous for A at -2518. These data identify a polymorphism in the MCP-1 distal regulatory region that affects the level of MCP-1 expression in response to an inflammatory stimulus. (C) 1999 Academic Press.
引用
收藏
页码:344 / 348
页数:5
相关论文
共 28 条
  • [1] EXPRESSION OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 MESSENGER-RNA IN HUMAN IDIOPATHIC PULMONARY FIBROSIS
    ANTONIADES, HN
    NEVILLEGOLDEN, J
    GALANOPOULOS, T
    KRADIN, RL
    VALENTE, AJ
    GRAVES, DT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) : 5371 - 5375
  • [2] BIRMINGHAM DJ, 1994, J IMMUNOL, V153, P691
  • [3] Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease
    Bouma, G
    Crusius, JBA
    Pool, MO
    Kolkman, JJ
    VonBlomberg, BME
    Kostense, PJ
    Giphart, MJ
    Schreuder, GMT
    Meuwissen, SGM
    Pena, AS
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1996, 43 (04) : 456 - 463
  • [4] POLYMORPHISM IN TUMOR-NECROSIS-FACTOR GENES ASSOCIATED WITH MUCOCUTANEOUS LEISHMANIASIS
    CABRERA, M
    SHAW, MA
    SHARPLES, C
    WILLIAMS, H
    CASTES, M
    CONVIT, J
    BLACKWELL, JM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) : 1259 - 1264
  • [5] Grandaliano G, 1996, J AM SOC NEPHROL, V7, P906
  • [6] HERITABLE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-ASSOCIATED DIFFERENCES IN PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA - RELEVANCE TO GENETIC PREDISPOSITION TO SYSTEMIC LUPUS-ERYTHEMATOSUS
    JACOB, CO
    FRONEK, Z
    LEWIS, GD
    KOO, M
    HANSEN, JA
    MCDEVITT, HO
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (03) : 1233 - 1237
  • [7] ENHANCED PRODUCTION OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 IN RHEUMATOID-ARTHRITIS
    KOCH, AE
    KUNKEL, SL
    HARLOW, LA
    JOHNSON, B
    EVANOFF, HL
    HAINES, GK
    BURDICK, MD
    POPE, RM
    STRIETER, RM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) : 772 - 779
  • [8] The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription
    Kroeger, KM
    Carville, KS
    Abraham, LJ
    [J]. MOLECULAR IMMUNOLOGY, 1997, 34 (05) : 391 - 399
  • [9] Lazarus M, 1997, J RHEUMATOL, V24, P2314
  • [10] Marsh CB, 1997, J IMMUNOL, V158, P1078